PHAIM PHARMA LTD
09355572Research and experimental development on biotechnology
PHAIM PHARMA LTD
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
16 Great Queen Street London WC2B 5AH England
Full company profile for PHAIM PHARMA LTD (09355572), an active life sciences and medical technology company based in London, England. Incorporated 15 Dec 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Cash in Bank
£98.00
Net Assets
-£791.05k
Total Liabilities
£860.52k
Turnover
N/A
Employees
5
Debt Ratio
1239%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 30 Jun Year End | 2023 30 Jun Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (1)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Apr 2020 | Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Daubeney, Piers Edward Francis, Prof | Director | British | England | 15 Dec 2014 | Active |
See all 10 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (4)
Hiam Orban Nee Jalahey
Hungarian
- Significant Influence Or Control
Prof Piers Edward Francis Daubeney
British
- Significant Influence Or Control
Dr Nara Daubeney
British
- Significant Influence Or Control
Tihamer Orban
Hungarian
- Ownership Of Shares 25 To 50 Percent
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 11 Feb 2026 | Confirmation Statement | Confirmation statement made on 24 Nov 2025 with updates | |
| 10 Feb 2026 | Capital | Allotment of shares (GBP 10,671) on 28 Mar 2024 | |
| 30 Jun 2025 | Accounts | Annual accounts made up to 30 Jun 2024 | |
| 3 Dec 2024 | Confirmation Statement | Confirmation statement made on 24 Nov 2024 with no updates | |
| 28 Jun 2024 | Accounts | Annual accounts made up to 30 Jun 2023 |
Confirmation statement made on 24 Nov 2025 with updates
Allotment of shares (GBP 10,671) on 28 Mar 2024
Annual accounts made up to 30 Jun 2024
Confirmation statement made on 24 Nov 2024 with no updates
Annual accounts made up to 30 Jun 2023
Recent Activity
Latest Activity
Confirmation statement made on 24 Nov 2025 with updates
4 months ago on 11 Feb 2026
Allotment of shares (GBP 10,671) on 28 Mar 2024
4 months ago on 10 Feb 2026
Annual accounts made up to 30 Jun 2024
12 months ago on 30 Jun 2025
Confirmation statement made on 24 Nov 2024 with no updates
1 years ago on 3 Dec 2024
Annual accounts made up to 30 Jun 2023
1 years ago on 28 Jun 2024